Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States

Journal of Addictive Diseases

Volumn 30, Issue 2, 2011, Pages 98-109

  Bini, Edmund J ^a   Kritz, Steven ^b   Brown, Lawrence S ^b,c   Robinson, Jim ^d   Alderson, Don ^e   Rotrosen, John ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Addiction Research and Treatment Corporation   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

barriers; drug abuse; hepatitis C virus; HIV AIDS; sexually transmitted infections

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; DRUG DEPENDENCE TREATMENT; FUNDING; GOVERNMENT REGULATION; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH PERSONNEL ATTITUDE; HEPATITIS C; HUMAN; MEDICAL EDUCATION; MEDICAL HISTORY; MEDICAL SERVICE; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT MONITORING; PHYSICAL EXAMINATION; SEXUALLY TRANSMITTED DISEASE; STAFF TRAINING; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES; HEALTH SERVICES ADMINISTRATION; HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROGRAM EVALUATION; QUESTIONNAIRES; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 79957519698     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2011.554780     Document Type: Conference Paper

References (28)

1. Centers for DiseaseControl and Prevention. Twentyfive years of HIV/AIDS: United States, 1981-2006. MMWR Morb Mortal Wkly Rep 2006; 55:585-9.
2. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705-14. (Pubitemid 46780630)
3. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2004. Atlanta, GA: U.S. Department of Health and Human Services, 2005.
4. WeinstockH,Berman S,CatesW. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36:6-10. (Pubitemid 38258322)
5. Anderson JE, Wilson RW, Barker P, Doll L, Jones TS, Holtgrave D. Prevalence of sexual and drug-related HIV risk behaviors in the U.S. adult population: results of the 1996 National Household Survey on Drug Abuse. J Acquir Immune Defic Syndr 1999; 21:148-56. (Pubitemid 29250079)
6. Bachmann LH, Lewis I, Allen R, Schwebke JR, Leviton LC, Siegal HA, Hook EW. Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility. Am J Public Health 2000; 90:1615-18.
7. Battjes RJ, Pickens RW, Brown LS. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:90-6.
8. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998; 47:1-39.
9. Francis H. Substance abuse and HIV infection. Top HIV Med 2003; 11:20-4.
10. Kral AH, Blumenthal RN, Booth RE, Watters JK. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health 1998; 88:108-13. (Pubitemid 28109653)
11. Plitt SS, Garfein RS, Gaydos CA, Strathdee SA, Sherman SG, Taha TE. Prevalence and correlates of chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis 2005; 32:446-53. (Pubitemid 40875382)
12. Santibanez SS, Garfein RS, Swartzendruber A, Purcell DW, Paxton LA, Greenberg AE. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health 2006; 83:86-100. (Pubitemid 44337045)
13. Hubbard RL, Craddock SG, Anderson J. Overview of 5-year follow-up outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat 2003; 25:125-34. (Pubitemid 37518373)
14. Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep 1998; 113 Suppl 1:97-106. (Pubitemid 29330151)
15. Metzger DS, Navaline H. HIV prevention among injection drug users: the need for integrated models. J Urban Health 2003; 80:59-66.
16. Reback CJ, Larkins S, Shoptaw S. Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment. AIDS Behav 2004; 8:87-98. (Pubitemid 38451001)
17. Schroeder JR, Epstein DH, Umbricht A, PrestonKL. Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence. Addict Behav 2006; 31:868-79.
18. Woody GE, Gallop R, Luborsky L, Blaine J, Frank A, Salloum IM, Gastfriend D, Crits-Christoph P. HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study. J Acquir Immune Defic Syndr 2003, 33: 82-87.
19. Substance Abuse &Mental Health Services Administration. SAMHSA Action Plan: HIV&Hepatitis FY 2006 and FY 2007. Rockville, MD, 2006.
20. Brown LS, Kritz SA, Goldsmith RJ, Bini EJ, Rotrosen J, Baker S, Robinson J, McAuliffe P. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat 2006; 30:315-21. (Pubitemid 44255783)
21. Pollack HA, D'Aunno T, Lamar B. Outpatient substance abuse treatment and HIV prevention: an update. J Subst Abuse Treat 2006; 30:39-47. (Pubitemid 41827932)
22. Substance Abuse & Mental Health Services Administration (SAMHSA). 2004 National Survey of Substance Abuse Treatment Programs (N-SSATS): data on SubstanceAbuse Treatment Facilities,DASIS Series: S-28, DHHS Publication No. (SMA) 05-4112; 2005a. Rockville, MD.
23. Strauss SM, Falkin GP, Vassilev Z, Des Jarlais D, Astone J. A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat 2002; 22:55-62. (Pubitemid 34257980)
24. Strauss SM, Astone JM., Des Jarlais D, Hagan H. A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States. Drug Alcohol Depend 2004; 73:227-36. (Pubitemid 38231034)
25. Rotrosen J, Leshner A, Tai B, Greenlick M, Pencer E, Trachtenberg R, et al. The National Drug Abuse Treatment ClinicalTrials Network: challenges and opportunities. NIDA Research Monograph Series 2002; 182:12-7.
26. Substance Abuse &Mental Health Services Administration. Results from the 2004 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-28, DHHS Publication No. SMA 05-4062) 2005b. Rockville, MD.
27. Kritz SA, Brown LS, Goldsmith RJ, Bini EJ, Robinson J, Alderson D, Novo P, Rotrosen J. States and substance abuse treatment programs: funding and guidelines for infection-related services. Am J Public Health 2008; 98:824-6. (Pubitemid 351671573)
28. National Treatment Center Study. Clinical Trials Network Summary & Comparison Report. NTCS Report No. 10. Athens, GA: Institute for Behavioral Research, University of Georgia 2005.